Summary
Updated Aug 31, 2026
George Magrath is Chief Executive Officer, Director of Opus Genetics, Inc. (IRD). 9 SEC Form 4 filings on record going back to 2024, most recently on 27 July 2026. Most recent open-market trade: sold $28K of IRD on 27 July 2026. Lifetime open-market purchases: $199K. Lifetime open-market sales: $205K. Historical track record: 1/5 stars across 3 tracked purchases.
Recent Transactions
10Every recent SEC Form 4 transaction George Magrath has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 33% |
| 90-day win rate | 67% |
| Avg 5-day return | +7.79% |
| Avg 30-day return | -2.08% |
| Avg 90-day return | +8.20% |
| Best 30-day return | +8.33% |
Trading Pattern
InsiderAlpha's records for George Magrath go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $66K (3 buys totaling $199K). The largest single buy on record is $98K of IRD in 2024. Sales side: 3 recorded sales totaling $205K, so the filing history runs sell-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies George Magrath files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Foundation Fighting Blindness Retinal Degeneration Fund - $7.39M of IRD open-market activity in the last 12 months
- Cam Gallagher - $324K of IRD open-market activity in the last 12 months
- Robert E. Gagnon - $64K of IRD open-market activity in the last 12 months
- Benjamin R. Yerxa - $61K of IRD open-market activity in the last 12 months
- Ashwath Jayagopal - $58K of IRD open-market activity in the last 12 months
- Joseph K. Schachle - $58K of IRD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is George Magrath?
George Magrath is a corporate insider, tracked as Chief Executive Officer, Director of Opus Genetics, Inc. (IRD). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has George Magrath submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has George Magrath been buying or selling stock?
Recorded transactions: 3 open-market purchases ($199K) and 3 open-market sales ($205K) across all tracked filings.
How accurate is George Magrath's historical track record?
Across 3 tracked purchases, George Magrath averaged -2.1% avg 30-day return with a 33% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of George Magrath's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow George Magrath and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial